ai-powered-parkinsons-disease-treatment-scientists-propose-an-updated-method

Treating Parkinson's disease with AI: scientists propose an updated method

 • 11384 переглядiв

Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms in some patients with Parkinson's disease. This has given scientists hope that the new method can help many other patients with the disease.

This is reported by UNN with reference to the Washington Post.

Features of Parkinson's disease

Like the heart, the brain has normal rhythms of electrical activity produced by neurons. Diseases such as epilepsy and schizophrenia are associated with abnormal brain rhythms, similar to cardiac arrhythmias. And in Parkinson's disease, neurons in the brain become too synchronized in a so-called oscillopathy. This can interfere with normal information transmission and lead to symptoms such as tremor and stiffness.

Imagine you're in a crowd, and there's a hum of conversation, but you can easily hear your own conversation — that's a normal situation of broadband neural activity. But with oscillopathy, it's like a protest march where everyone is chanting the same thing, and you can't hear yourself speak

- explained Helen Bronte-Stewart, professor of neurology and neurological sciences at Stanford School of Medicine. 

Dementia can be prevented: lowering bad cholesterol levels can significantly reduce the risk of developing the disease02.04.25, 16:36 • [views_16202]

Methods of combating the disease

Deep brain stimulation (DBS) is a surgical therapy for treating the symptoms of Parkinson's disease. A device similar to a pacemaker is implanted in the brain to deliver electrical impulses. This treatment method has been used since 1997.

Adaptive brain stimulation method

According to experts, DBS and Parkinson's disease medications weaken oscillopathy in the brain. In particular, constant electrical impulses from DBS help stimulate neuron activation in such a way, returning brain rhythms to normal.

Early detection of Parkinson's disease: a new test will help you avoid waiting for symptoms for years21.03.24, 14:39 • [views_24734]

Conventional DBS provides electrical stimulation at a constant setting. This can lead to periods of under- and overstimulation, which in turn leads to slowed movements or dyskinesia, respectively.

The updated, adaptive brain stimulation method personalizes therapy based on the patient's real-time brain activity using AI.

In February, the Food and Drug Administration approved the first adaptive DBS system for people with Parkinson's disease.

For some patients, especially those with more severe symptoms, standard DBS, which is always on in one constant mode, does not provide sufficient benefit. The brain's needs change depending on their activity level, for example, when they are awake or asleep, and especially according to the medication cycle

- noted Philip Starr, professor of neurological surgery at the University of California, San Francisco.

Hypotension: what it is and why it is dangerous21.10.24, 12:19 • [views_14881]

Research

Previous studies have shown that adaptive DBS improves motor control, has fewer side effects, and delivers less electrical energy compared to conventional DBS.

In 2024, Starr and his colleagues conducted a pilot study involving four patients with Parkinson's disease. It found that adaptive DBS improved motor symptoms and quality of life compared to conventional DBS.

The researchers personalized the algorithms for each patient by bringing them to the clinic and measuring their brain rhythm while taking or excluding levodopa, a Parkinson's drug used to increase dopamine levels.

One way to develop these kinds of algorithms is to first do some brain signal studies under known conditions. Then you can train an artificial intelligence algorithm on this known data so that the AI program learns what combination of brain signals is associated with different states

- explained Starr.

Parkinson's disease will affect more than 25 million people by 2050 - research19.03.25, 21:39 • [views_22261]

Clinical trial

The ADAPT-PD clinical trial included 68 patients with Parkinson's disease who had previously been implanted with a conventional DBS system. They were fitted with adaptive DBS and sent home for 30 days.

Although the full results of the study have not yet been published, preliminary data showed no serious side effects, and 98% of participants chose to remain on adaptive DBS during long-term follow-up.

Risks and contraindications

Experts note that adaptive DBS or conventional DBS will not benefit every patient. Both motor and non-motor symptoms (postural instability, stiffness, gastrointestinal problems, and sleep problems) may still remain.

In addition, any surgery carries risks, and people with heart disease and high blood pressure are more likely to develop infection, stroke, brain hemorrhage, or anesthesia-related complications.

Not everyone with Parkinson's disease is a good candidate for any type of DBS. Patients must have a good response to dopaminergic drugs such as levodopa and should not be too advanced in their disease

- noted Bronte-Stewart.

Currently, scientists continue to improve adaptive deep brain stimulation, but hope that the new method can help many other patients with Parkinson's disease.

For the first time, researchers have traced the formation of amyloids associated with Alzheimer's disease with unprecedented accuracy04.11.24, 12:22 • [views_19089]

Popular
Denmark to reduce aid to Ukraine in 2026

 • 5428 переглядiв

Sweden stops aid to five countries and redirects money to support Ukraine

 • 3772 переглядiв

Netflix announced it is buying Warner Bros. and HBO

 • 16138 переглядiв

News by theme
Treating Parkinson's disease with AI: scientists propose an updated method

 • 11384 переглядiв

Man beat a horse with a stick at a ski resort: the police have taken up the case

 • 10450 переглядiв

Semi-final of the Ukrainian Football Cup: draw results

 • 9133 переглядiв